Literature DB >> 18049028

Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension.

Jing Tan1, Qi Hua, Xiurong Xing, Jing Wen, Rongkun Liu, Zheng Yang.   

Abstract

The extracellular matrix is vital for maintaining tissue integrity, and the matrix metalloproteinases/tissue inhibitors of metalloproteinases (MMPs/TIMPs) system is involved in the regulation of extracellular matrix metabolism. Extracellular matrix turnover plays an important role in the change of large arterial mechanical properties in hypertension. However, the association of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 (MMP-9/TIMP-1) system and arterial stiffness is not straightforward and existing data are rather limited. Our objective is to explore the impact of the MMP-9/TIMP-1 system on large arterial stiffness in patients with essential hypertension. An automatic pulse wave velocity (PWV) measuring system was used to examine carotid-femoral PWV (CFPWV) and carotid-radial PWV (CRPWV) as the parameters reflecting central elastic large arterial and peripheral muscular medium-sized arterial elasticity, respectively; and serum MMP-9 and TIMP-1 levels, along with a number of other established biomarkers, were measured by enzyme-linked immunosorbent assay (ELISA) in 202 essential hypertensive patients and 54 age and gender-matched control subjects. Compared with the control subjects, hypertensive patients exhibited higher levels of MMP-9 (p=0.001) and TIMP-1 (p=0.002). Spearman's correlation analysis showed that serum levels of MMP-9 (p=0.014) and TIMP-1 (p=0.005) were significantly and positively correlated with CFPWV in hypertensive patients. A stepwise multiple regressive analysis demonstrated that age, systolic blood pressure, heart rate and TIMP-1 were independent predictors of CFPWV in patients with essential hypertension (adjusted r2=0.458). In conclusion, our results imply that the MMP-9/TIMP-1 system may play an important role in the determination of arterial function, and these findings may have implications for the involvement of MMP-9/TIMP-1 system in the pathophysiology of cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18049028     DOI: 10.1291/hypres.30.959

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  28 in total

Review 1.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

2.  Tissue Inhibitor of Metalloproteinase-1: Actions beyond Matrix Metalloproteinase Inhibition.

Authors:  Merry L Lindsey; Andriy Yabluchanskiy; Yonggang Ma
Journal:  Cardiology       Date:  2015-08-01       Impact factor: 1.869

Review 3.  Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.

Authors:  Jie Liu; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-10       Impact factor: 3.622

Review 4.  The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.

Authors:  Griselda A Cabral-Pacheco; Idalia Garza-Veloz; Claudia Castruita-De la Rosa; Jesús M Ramirez-Acuña; Braulio A Perez-Romero; Jesús F Guerrero-Rodriguez; Nadia Martinez-Avila; Margarita L Martinez-Fierro
Journal:  Int J Mol Sci       Date:  2020-12-20       Impact factor: 5.923

Review 5.  Role of Thioredoxin in Age-Related Hypertension.

Authors:  Kumuda C Das; Venkatesh Kundumani-Sridharan; Jaganathan Subramani
Journal:  Curr Hypertens Rep       Date:  2018-02-14       Impact factor: 5.369

Review 6.  An emerging role of degrading proteinases in hypertension and the metabolic syndrome: autodigestion and receptor cleavage.

Authors:  Geert W Schmid-Schönbein
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

7.  Rice bran protein hydrolysates reduce arterial stiffening, vascular remodeling and oxidative stress in rats fed a high-carbohydrate and high-fat diet.

Authors:  Ketmanee Senaphan; Weerapon Sangartit; Poungrat Pakdeechote; Veerapol Kukongviriyapan; Patchareewan Pannangpetch; Supawan Thawornchinsombut; Stephen E Greenwald; Upa Kukongviriyapan
Journal:  Eur J Nutr       Date:  2016-09-22       Impact factor: 5.614

8.  Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease.

Authors:  Ryan S Friese; Fangwen Rao; Srikrishna Khandrika; Brenda Thomas; Michael G Ziegler; Geert W Schmid-Schönbein; Daniel T O'Connor
Journal:  Clin Exp Hypertens       Date:  2009-10       Impact factor: 1.749

9.  Differential effect of wall tension on matrix metalloproteinase promoter activation in the thoracic aorta.

Authors:  Jean Marie Ruddy; Jeffrey A Jones; Robert E Stroud; Rupak Mukherjee; Francis G Spinale; John S Ikonomidis
Journal:  J Surg Res       Date:  2009-01-24       Impact factor: 2.192

10.  Metalloproteinase-3 genotype as a predictor of cardiovascular risk in hypertensive adolescents.

Authors:  Yun Hee Lee; Tae Yeon Kim; Young Mi Hong
Journal:  Korean Circ J       Date:  2009-08-27       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.